Patients admitted within ≤2 days and with Hb ≥ 8 g/dL had excellent survival (>95%), whereas those with delayed admission (≥3 days) and severe anemia (Hb < 8 g/dL) experienced the highest mortality (>70%). This evidence concerns the gene GSTM1 and anemia (phenotype).